next generation RDP-58 (Sangstat/Synt:em)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namenext generation RDP-58 (Sangstat/Synt:em)
Drug Alias NameRDP-58 follow up (SangStat/Synt:em)6-XRDP-59
ClassificationSmall molecules
Mechanisms of ActionTNF synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSangstat Medical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSangstat Medical Corp
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A